ID
int64
1
9.11k
age
float64
18
102
death
int64
0
1
sex
stringclasses
2 values
hospdead
int64
0
1
slos
int64
3
343
d.time
int64
3
2.03k
dzgroup
stringclasses
8 values
dzclass
stringclasses
4 values
num.co
int64
0
9
edu
float64
0
31
income
stringclasses
4 values
scoma
float64
0
100
charges
float64
1.17k
1.44M
totcst
float64
0
633k
totmcst
float64
-102.72
711k
avtisst
float64
1
83
race
stringclasses
5 values
sps
float64
0.2
99.2
aps
float64
0
143
surv2m
float64
0
0.97
surv6m
float64
0
0.95
hday
int64
1
148
diabetes
int64
0
1
dementia
int64
0
1
ca
stringclasses
3 values
prg2m
float64
0
1
prg6m
float64
0
1
dnr
stringclasses
3 values
dnrday
float64
-88
285
meanbp
float64
0
195
wblc
float64
0
200
hrt
float64
0
300
resp
float64
0
90
temp
float64
31.7
41.7
pafi
float64
12
890
alb
float64
0.4
29
bili
float64
0.1
63
crea
float64
0.1
21.5
sod
float64
110
181
ph
float64
6.83
7.77
glucose
float64
0
1.09k
bun
float64
1
300
urine
float64
0
9k
adlp
float64
0
7
adls
float64
0
7
sfdm2
stringclasses
5 values
adlsc
float64
0
7.07
8,301
57.10098
1
female
0
4
1,000
Lung Cancer
Cancer
1
11
$11-$25k
0
2,784
1,590.1895
914.3999
13
white
14.599609
13
0.767944
0.519897
1
0
0
metastatic
0.95
0.75
no dnr
4
104
10.599609
69
24
38.09375
null
null
0.199982
1.099854
132
null
null
null
null
null
0
no(M2 and SIP pres)
0
8,302
83.19495
1
female
0
3
89
Lung Cancer
Cancer
2
12
null
0
1,538
1,025.7471
985.06982
15
white
24.597656
27
0.465942
0.15097
1
1
0
metastatic
0.6
0.4
dnr after sadm
1
74
12.298828
77
24
36.69531
null
2.699707
0.599976
0.899902
134
null
null
null
null
null
null
adl>=4 (>=5 if sur)
2.966797
8,303
70.82495
1
female
0
8
1,135
COPD
COPD/CHF/Cirrhosis
2
14
null
26
5,587
3,600.9805
3,241.47852
9.5
white
20.597656
38
0.762939
0.622925
1
0
0
no
0.95
0.85
dnr after sadm
1
77
17.398438
71
28
36.19531
236
null
null
1.5
134
7.379883
null
null
null
null
1
adl>=4 (>=5 if sur)
1
8,304
69.15295
0
male
0
8
1,440
COPD
COPD/CHF/Cirrhosis
3
null
null
0
10,159
6,785.2852
6,877.88672
10.5
white
18
29
0.843994
0.743896
4
0
0
no
0.8
0.6
no dnr
8
102
11
66
24
35.69531
224
3.899902
0.899902
1.199951
131
7.239258
null
null
null
null
null
null
3.24707
8,305
73.08398
1
male
0
12
76
ARF/MOSF w/Sepsis
ARF/MOSF
4
8
under $11k
0
14,307
10,014.0859
10,173.5391
19
white
17.898438
26
0.822998
0.762939
1
0
0
yes
0.95
0.9
no dnr
12
75
11.298828
70
24
36.39844
268
3.899902
1.099854
1.399902
137
7.389648
null
null
null
null
0
null
0
8,306
65.396
1
male
0
12
147
CHF
COPD/CHF/Cirrhosis
7
11
under $11k
0
7,884
5,273.1055
6,633.85938
6
white
15.298828
46
0.901978
0.835938
1
1
0
no
0.8
0.6
no dnr
12
79
9.599609
73
28
36.39844
null
4.599609
0.799927
3
139
null
null
null
null
0
0
no(M2 and SIP pres)
0
8,307
75.93695
1
male
1
17
17
CHF
COPD/CHF/Cirrhosis
5
6
$11-$25k
0
24,965
16,674.9531
16,149.3281
20.333328
white
26.398438
35
0.727905
0.574951
1
1
0
no
0.2
0.1
dnr after sadm
3
70
12.798828
110
40
37.59375
210
2.899902
0.799927
1.399902
136
7.449219
null
null
null
null
7
<2 mo. follow-up
7
8,308
54.34399
1
male
0
3
207
Lung Cancer
Cancer
2
11
>$50k
0
1,509
1,049.8047
1,218.58984
5
white
18.597656
16
0.700928
0.414978
1
0
0
metastatic
0.6
0.4
no dnr
3
81
null
96
28
35.79688
null
null
null
null
140
null
null
null
null
null
0
no(M2 and SIP pres)
0
8,309
73.34698
0
female
0
11
1,439
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
0
18,090
11,908.6641
12,040.9531
20.5
white
22
22
0.765991
0.690918
6
0
0
no
0.75
0.6
no dnr
11
120
23.398438
60
24
36.69531
145
3.899902
0.399963
1
141
7.429688
null
null
null
null
5
no(M2 and SIP pres)
5
8,310
77.43195
1
male
0
12
432
Lung Cancer
Cancer
1
null
null
0
13,719
null
null
6.5
white
8.699219
17
0.820923
0.612915
1
0
0
metastatic
0.99
0.95
no dnr
12
113
12.599609
76
20
36.39844
null
4.099609
0.599976
1.199951
141
null
null
null
null
null
null
null
2.520508
8,311
76.73096
1
female
1
36
36
ARF/MOSF w/Sepsis
ARF/MOSF
2
7
$11-$25k
37
83,635
61,648.1562
61,913.9062
24.75
white
39.59375
58
0.112991
0.047997
12
0
0
no
0.1
0.001
no dnr
36
53
16.398438
134
12
35.59375
152
2.399902
1.799805
2.599609
146
7.439453
null
null
null
null
0
<2 mo. follow-up
0
8,312
61.45398
1
male
1
35
35
MOSF w/Malig
ARF/MOSF
0
12
under $11k
9
154,093
101,554.438
115,426.5
43.5
white
29.398438
51
0.416992
0.296997
19
0
0
yes
0.1
0.001
dnr after sadm
7
73
0.199982
110
30
39.5
253.3125
null
null
1.399902
139
7.5
null
null
null
null
null
<2 mo. follow-up
1.907715
8,313
50.133
1
male
0
15
22
Cirrhosis
COPD/CHF/Cirrhosis
1
14
under $11k
0
28,895
20,353.9219
20,749.3125
28.666656
white
22.796875
40
0.803955
0.68396
1
0
0
no
0.7
0.6
no dnr
15
67
11.699219
134
10
39.59375
233.3125
2.5
1.099854
0.899902
138
7.419922
null
null
null
null
null
<2 mo. follow-up
2.691895
8,314
85.96295
1
female
0
6
1,328
ARF/MOSF w/Sepsis
ARF/MOSF
0
8
null
0
6,391
4,357.6367
4,165.54688
20
white
26.398438
36
0.67688
0.582886
1
0
0
no
0.9
0.5
no dnr
6
79
23.796875
116
32
38.69531
186.65625
4.099609
0.199982
0.699951
131
7.489258
null
null
null
null
1
no(M2 and SIP pres)
1
8,315
69.47797
1
male
1
7
7
MOSF w/Malig
ARF/MOSF
3
12
under $11k
0
25,801
16,894.9688
19,424.7656
40.5
white
41.5
54
0.098999
0.040993
4
0
0
metastatic
0.1
0.001
no dnr
7
105
16.296875
120
34
38.19531
86.25
null
null
2.699707
124
7.509766
null
null
null
null
2
<2 mo. follow-up
2
8,316
70.836
1
male
0
4
122
Lung Cancer
Cancer
1
7
under $11k
0
3,294
1,952.7148
1,427.48926
7
white
9
20
0.826904
0.623901
1
0
0
metastatic
0.9
0.5
no dnr
4
119
5.5
98
24
36.5
null
4.099609
0.399963
1.099854
136
null
null
null
null
null
null
no(M2 and SIP pres)
1.772217
8,317
70.86395
1
male
0
6
982
CHF
COPD/CHF/Cirrhosis
2
8
$11-$25k
0
5,788
4,110.832
3,670.69922
20
white
21.898438
32
0.819946
0.707886
1
0
0
no
0.5
0.25
dnr after sadm
1
53
10.099609
56
12
38.39844
null
2.699707
1.799805
1
133
null
null
null
null
0
null
no(M2 and SIP pres)
0.4948
8,318
80.58295
1
male
1
14
14
COPD
COPD/CHF/Cirrhosis
4
null
null
0
22,019
14,455.2656
14,269.1328
29
white
21.898438
32
0.747925
0.602905
1
0
0
no
0.5
0.1
dnr after sadm
4
70
8.599609
77
30
38.29688
137.5
3.099609
0.5
0.699951
138
7.399414
null
null
null
null
null
<2 mo. follow-up
3.407227
8,319
53.81198
1
male
0
8
173
Lung Cancer
Cancer
2
12
$11-$25k
0
4,288
3,318.6133
3,390.82812
2
white
15.298828
11
0.762939
0.511963
1
0
0
metastatic
null
null
no dnr
8
113
9.099609
56
20
36.19531
null
3.699707
0.299988
1
133
null
null
null
null
null
0
no(M2 and SIP pres)
0
8,320
77.58197
0
female
0
6
1,421
COPD
COPD/CHF/Cirrhosis
0
null
null
9
8,004
5,128.5703
5,097.39844
10
white
16.898438
32
0.806885
0.687988
2
0
0
no
0.9
0.75
no dnr
6
115
null
74
22
36.29688
184
null
null
null
140
7.289062
null
null
null
null
null
null
2.940918
8,321
54.689
0
female
0
7
1,422
ARF/MOSF w/Sepsis
ARF/MOSF
2
10
under $11k
0
6,362
4,323.1992
4,391.4375
17
white
26.699219
34
0.802979
0.737915
1
0
0
no
0.99
0.99
no dnr
7
65
3.199707
72
24
36.19531
null
2.799805
0.299988
4.199219
135
null
null
null
null
0
null
no(M2 and SIP pres)
0.4948
8,322
66.00397
1
male
0
6
104
Lung Cancer
Cancer
2
8
null
0
5,387
3,580.7188
3,115.80859
13
white
21.097656
22
0.615967
0.300964
1
0
0
metastatic
null
null
no dnr
6
79
7.299805
130
24
38.5
null
3.799805
0.399963
1.099854
123
null
null
null
null
1
0
no(M2 and SIP pres)
0
8,323
88.04395
1
male
0
5
100
CHF
COPD/CHF/Cirrhosis
4
8
under $11k
9
2,461
1,665.71
1,532.65918
6
white
21.898438
34
0.718994
0.56189
1
1
1
no
0.25
0.25
no dnr
5
102
null
83
24
36
null
null
0.299988
2.699707
132
null
null
null
null
6
4
no(M2 and SIP pres)
4
8,324
66.32397
1
male
0
19
902
MOSF w/Malig
ARF/MOSF
2
12
$11-$25k
0
30,250
20,162.25
19,742.6562
17.333328
white
20.796875
39
0.709961
0.621948
5
1
0
yes
0.8
0.6
no dnr
19
67
8.298828
65
10
38.59375
85.70312
1.799805
0.299988
1.099854
134
7.439453
null
null
null
null
0
null
0
8,325
62.63699
1
male
0
6
423
CHF
COPD/CHF/Cirrhosis
1
11
under $11k
0
4,544
2,984.0488
3,243.36914
9
white
20.296875
30
0.86499
0.775879
1
1
0
no
0.95
0.8
no dnr
6
75
8.5
60
20
36.59375
107.5
3.899902
0.699951
1.199951
136
7.389648
null
null
null
0
null
no(M2 and SIP pres)
0.4948
8,326
74.92096
1
male
0
5
6
ARF/MOSF w/Sepsis
ARF/MOSF
2
8
$11-$25k
41
28,116
18,203.4219
20,067.8438
44
white
34.09375
71
0.173981
0.087997
8
1
0
yes
0
0
dnr after sadm
2
67
0.399963
104
32
39.5
265.6875
3.199707
2
2.899902
141
7.439453
null
null
null
null
5
<2 mo. follow-up
5
8,327
60.62097
1
female
0
14
36
COPD
COPD/CHF/Cirrhosis
2
9
>$50k
0
42,474
27,756.9531
30,864.4219
23
white
25.097656
43
0.826904
0.718994
1
0
0
no
0.05
0.000125
dnr after sadm
2
56
19.898438
160
32
36.69531
220
3.699707
0.399963
0.699951
139
7.419922
null
null
null
null
0
<2 mo. follow-up
0
8,328
62.86099
0
male
0
5
1,417
CHF
COPD/CHF/Cirrhosis
4
13
$25-$50k
0
3,150
2,122.1133
2,094.81836
6
white
9.599609
24
0.940918
0.898926
1
1
0
no
0.8
0.5
no dnr
5
65
7.799805
79
24
36.09375
261.875
4.699219
0.799927
0.899902
133
7.469727
null
null
null
null
1
no(M2 and SIP pres)
1
8,329
68.99695
1
male
0
6
1,124
COPD
COPD/CHF/Cirrhosis
3
9
under $11k
0
3,835
2,503.3379
2,893.29883
3
white
13.099609
19
0.908936
0.846924
1
0
0
no
0.6
0.4
no dnr
6
80
6.599609
101
28
36.59375
307.375
4.799805
0.299988
0.5
138
7.379883
null
null
null
null
null
no(M2 and SIP pres)
2.216797
8,330
64.85394
0
male
0
9
1,410
COPD
COPD/CHF/Cirrhosis
2
12
null
0
6,961
4,712.75
4,549.83984
13.5
white
16.296875
39
0.897949
0.829956
1
0
0
no
null
null
no dnr
9
132
6
148
28
36.09375
248.125
4.399414
0.5
1
143
7.339844
null
null
null
0
1
no(M2 and SIP pres)
1
8,331
66.76495
0
female
0
6
1,411
COPD
COPD/CHF/Cirrhosis
4
8
under $11k
0
7,166
4,621.0664
5,069.59766
22
white
19.898438
31
0.822998
0.710938
1
0
0
yes
0.5
0.25
dnr after sadm
3
107
11.898438
126
24
36.5
300
3.599609
0.399963
0.899902
137
7.5
null
null
null
null
0
no(M2 and SIP pres)
0
8,332
44.48199
0
female
0
13
1,410
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
$11-$25k
0
15,664
10,359.6328
10,514.7656
18.5
white
29.898438
49
0.792969
0.724976
1
0
0
no
null
null
no dnr
13
110
19.199219
142
28
38.69531
173.46875
2.599609
0.399963
2.699707
138
7.469727
null
null
null
0
0
no(M2 and SIP pres)
0
8,333
54.40097
1
female
0
7
260
COPD
COPD/CHF/Cirrhosis
3
13
$11-$25k
0
7,488
5,050.7344
5,283.14844
13
white
16.5
25
0.92688
0.875977
1
0
0
no
0.65
0.6
no dnr
7
63
16.699219
107
24
36.39844
204
4.199219
0.199982
0.799927
140
7.479492
null
null
null
1
null
no(M2 and SIP pres)
1.1669
8,334
65.02899
0
male
0
19
1,409
COPD
COPD/CHF/Cirrhosis
1
null
null
9
56,325
35,421.8438
39,795.4688
27.666656
white
17.398438
34
0.873901
0.790894
1
0
0
no
0.7
0.5
no dnr
19
113
9.099609
146
30
38.29688
202.03125
4.199219
0.599976
1.299805
134
7.469727
null
null
null
null
null
null
2.938965
8,335
81.48096
1
female
1
3
3
Coma
Coma
0
16
null
100
32,997
21,490.9688
27,210.6562
14
white
21.199219
32
0.056
0.028999
27
0
0
no
null
null
dnr after sadm
3
117
null
134
32
38.5
377.75
3.099609
0.699951
1.099854
131
7.489258
null
null
null
null
null
<2 mo. follow-up
2.612793
8,336
71.737
0
male
0
5
1,406
Lung Cancer
Cancer
2
12
$11-$25k
0
3,561
2,334.3106
1,967.94922
7
white
5.799805
14
0.862915
0.69397
1
0
0
metastatic
0.99
0.99
no dnr
5
110
7.299805
89
20
35.69531
null
4.399414
0.199982
1
137
null
null
null
null
null
null
no(M2 and SIP pres)
1.791748
8,337
80.02197
1
female
0
3
350
CHF
COPD/CHF/Cirrhosis
4
8
null
0
1,665
1,115.0947
1,304.96973
18
white
17.5
33
0.844971
0.744995
1
1
1
no
0.85
0.7
dnr after sadm
1
73
4.199219
104
20
35.89844
314.25
4.099609
0.599976
1.699951
135
7.399414
null
null
null
null
null
no(M2 and SIP pres)
4.041992
8,338
93.41498
1
female
0
10
1,325
CHF
COPD/CHF/Cirrhosis
3
8
under $11k
0
6,652
4,363.7539
3,876.33984
7.5
white
18.097656
17
0.787964
0.658936
1
0
0
no
0.5
0.25
dnr before sadm
-1
85
17.898438
64
24
36.29688
null
3.399902
0.599976
0.899902
136
null
null
null
null
null
5
adl>=4 (>=5 if sur)
5
8,339
57.952
1
male
0
7
211
Lung Cancer
Cancer
1
7
$25-$50k
0
3,660
2,429.7559
2,444.68945
9
white
10.5
16
0.826904
0.623901
1
0
0
metastatic
0.8
0.3
no dnr
7
63
8.599609
62
24
36.09375
null
4.099609
0.5
1.199951
133
null
null
null
null
2
1
no(M2 and SIP pres)
1
8,340
81.11395
1
male
0
50
818
ARF/MOSF w/Sepsis
ARF/MOSF
5
12
$11-$25k
26
91,897
61,603.1875
62,473.7188
40
white
30.199219
58
0.307983
0.195984
9
0
0
yes
null
null
no dnr
50
51
null
68
28
35.89844
242.84375
null
null
4.799805
135
7.279297
null
null
null
null
1
adl>=4 (>=5 if sur)
1
8,341
73.70294
0
male
0
10
1,401
COPD
COPD/CHF/Cirrhosis
2
12
$11-$25k
0
6,145
3,975.1602
3,636.23828
6
white
20
27
0.821899
0.709961
1
0
0
no
1
1
no dnr
10
75
14.798828
69
28
35.5
240
null
null
0.899902
138
7.429688
null
null
null
null
0
no(M2 and SIP pres)
0
8,342
64.07898
1
female
0
4
278
Colon Cancer
Cancer
1
14
under $11k
9
2,834
1,935.4111
1,768.78906
9
white
15.599609
14
0.816895
0.605957
1
0
0
metastatic
0.8
0.3
no dnr
4
76
null
93
16
36.29688
null
null
null
null
140
null
null
null
null
null
0
null
0
8,343
58.905
1
female
0
5
93
Lung Cancer
Cancer
2
15
$25-$50k
0
3,402
2,032.0908
1,692.66992
9
white
7.099609
12
0.86499
0.696899
1
0
0
metastatic
0.5
0.15
no dnr
5
121
17.796875
96
20
37.39844
null
4.299805
0.599976
1
139
null
null
null
null
null
1
adl>=4 (>=5 if sur)
1
8,344
52.90097
1
female
0
6
1,379
CHF
COPD/CHF/Cirrhosis
5
null
null
0
4,159
2,839.4883
2,726.63867
14
white
17.296875
16
0.912964
0.852905
1
0
0
no
0.9
0.6
no dnr
6
109
9.298828
118
20
36.39844
null
3.799805
0.299988
1.199951
136
null
null
null
null
null
null
null
3.262695
8,345
71.05499
1
female
1
10
10
MOSF w/Malig
ARF/MOSF
2
14
under $11k
0
21,861
14,073.1797
13,974.7734
28
white
24.097656
39
0.687988
0.595947
1
0
0
yes
0.5
0.3
dnr after sadm
3
55
14.798828
116
31
38.29688
296.625
2.799805
0.399963
1.299805
134
7.419922
null
null
null
null
null
<2 mo. follow-up
2.076172
8,346
76.28998
1
male
1
4
4
Lung Cancer
Cancer
2
12
$11-$25k
0
4,655
2,850.7129
2,189.58984
21
white
25.398438
58
0.46698
0.151978
1
0
0
metastatic
null
null
no dnr
4
69
0.899902
126
36
35.69531
null
null
null
0.899902
132
null
null
null
null
null
null
<2 mo. follow-up
2.731934
8,347
64.93097
0
female
0
43
1,393
ARF/MOSF w/Sepsis
ARF/MOSF
3
10
under $11k
0
85,693
57,021
59,819.8125
35.75
white
27.898438
39
0.745972
0.665894
1
0
0
no
0.5
0.2
no dnr
43
74
24.296875
125
42
38.09375
148
null
null
0.799927
141
7.479492
null
null
null
null
7
adl>=4 (>=5 if sur)
7
8,348
73.74896
1
female
1
9
9
Coma
Coma
1
null
under $11k
44
21,303
14,874.0625
15,504.2734
29.5
white
27.699219
44
0.233978
0.168976
4
0
0
no
0.6
0.6
dnr after sadm
9
129
14.298828
114
40
36.5
166
null
null
1.5
139
7.439453
null
null
null
null
0
<2 mo. follow-up
0
8,349
35.11298
1
female
0
11
106
MOSF w/Malig
ARF/MOSF
2
12
$11-$25k
0
12,351
8,735.1953
9,415.82812
14.5
white
30.296875
33
0.523926
0.407959
1
0
0
metastatic
0.9
0.8
no dnr
11
45
1.699951
76
26
37.89844
null
3.699707
0.5
1.199951
138
null
null
null
null
5
null
no(M2 and SIP pres)
3.855299
8,350
88.52295
1
male
1
6
6
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$25-$50k
0
11,769
7,572.7656
6,856.42969
39
white
27.597656
41
0.563965
0.451965
1
0
0
yes
0.1
0.001
no dnr
6
106
29.796875
70
41
38
110.20312
2.899902
1.199951
1.399902
132
7.429688
null
null
null
null
0
<2 mo. follow-up
0
8,351
62.92999
0
male
0
14
1,391
Coma
Coma
1
12
null
0
32,123
21,794.6094
26,767.9062
43.666657
white
23.5
28
0.691895
0.637939
2
1
0
no
0.7
0.5
no dnr
14
96
10.199219
102
40
39.19531
164.4375
3.599609
0.799927
1.299805
142
7.419922
null
null
null
null
null
no(M2 and SIP pres)
1.665527
8,352
58.55197
1
male
0
5
74
Colon Cancer
Cancer
1
12
null
0
3,079
1,990.9004
1,955.76953
11
white
22.097656
38
0.75293
0.494995
1
0
0
metastatic
0.25
0.05
no dnr
5
115
5.799805
124
20
36.59375
null
3.299805
16.796875
1.099854
135
null
null
null
null
null
null
adl>=4 (>=5 if sur)
1.841553
8,353
64.24396
0
male
0
6
1,390
CHF
COPD/CHF/Cirrhosis
2
12
null
0
4,388
2,943.1934
2,494.30859
9
white
22.097656
33
0.840942
0.73999
1
0
0
no
0.98
0.98
no dnr
6
72
7.099609
48
20
35.69531
323.75
null
null
1.699951
136
7.40918
null
null
null
0
0
no(M2 and SIP pres)
0
8,354
57.36099
0
female
0
11
1,390
COPD
COPD/CHF/Cirrhosis
2
8
$11-$25k
0
16,935
null
null
13
white
24.097656
38
0.85498
0.761963
1
0
0
no
0.6
0.6
dnr after sadm
10
66
11.099609
114
36
39.59375
192.5625
2.699707
1.5
1
135
7.40918
null
null
null
null
3
no(M2 and SIP pres)
3
8,355
50.18997
1
male
0
6
100
Lung Cancer
Cancer
4
12
>$50k
0
3,883
2,523.0332
2,455.57812
9
white
22.296875
18
0.630981
0.31897
1
1
0
metastatic
0.2
0.05
dnr after sadm
1
77
10.398438
70
20
35.69531
null
3.299805
0.199982
0.599976
132
null
null
null
null
2
2
no(M2 and SIP pres)
2
8,356
62.37399
0
female
0
6
1,388
COPD
COPD/CHF/Cirrhosis
3
12
null
0
5,885
3,970.6641
4,407.62891
16
white
19.597656
23
0.879883
0.799927
1
0
0
no
0.8
0.7
no dnr
6
83
8.5
101
20
36.79688
180.9375
4.299805
0.5
0.699951
127
7.449219
null
null
null
null
null
null
2.464356
8,357
79.07697
1
male
0
6
828
COPD
COPD/CHF/Cirrhosis
3
11
under $11k
0
4,192
2,770.7383
2,595.36914
7
white
22.398438
53
0.75
0.60498
1
0
0
no
0.8
0.5
no dnr
6
121
5.699219
215
28
36.19531
219.03125
null
null
1.199951
143
7.349609
null
null
null
null
null
no(M2 and SIP pres)
2.876953
8,358
70.48596
0
female
0
23
1,385
ARF/MOSF w/Sepsis
ARF/MOSF
1
16
$11-$25k
0
28,320
18,725.5
18,765.2656
18.666656
white
37
41
0.477966
0.359985
2
0
0
no
0.7
0.7
no dnr
23
65
18.597656
146
38
39.39844
104.07812
2.699707
1.5
0.5
130
7.359375
null
null
null
null
null
adl>=4 (>=5 if sur)
2.195313
8,359
71.91498
1
male
0
9
650
Cirrhosis
COPD/CHF/Cirrhosis
2
17
$25-$50k
0
5,357
3,685.5586
3,325.11914
9
white
15.798828
16
0.78894
0.660889
1
0
0
no
0.9
0.95
no dnr
9
95
6.899414
64
24
36.69531
null
3
1.599854
1.199951
145
null
null
null
null
0
0
no(M2 and SIP pres)
0
8,360
68.35596
1
male
0
24
841
ARF/MOSF w/Sepsis
ARF/MOSF
2
7
under $11k
61
56,732
37,232.125
39,466.4375
30.666656
white
35.09375
69
0.18399
0.095993
6
0
0
no
0.08
0.000512
dnr after sadm
10
113
26.699219
64
28
38.19531
132
2.199707
10.798828
3
141
7.429688
null
null
null
null
0
adl>=4 (>=5 if sur)
0
8,361
64.06598
0
male
0
16
1,377
Lung Cancer
Cancer
2
8
$11-$25k
0
21,757
13,109.3281
14,360.9375
21.666656
white
10.298828
25
0.819946
0.610962
1
0
0
metastatic
0.8
0.7
no dnr
16
64
8
76
10
38.09375
276.1875
4
0.299988
0.699951
133
7.40918
null
null
null
null
2
no(M2 and SIP pres)
2
8,362
70.37097
1
female
1
43
43
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
under $11k
0
98,681
67,149.75
74,074.8125
43
white
27.796875
51
0.656982
0.55896
8
0
0
no
0.5
0.5
dnr after sadm
42
65
22.398438
72
40
37.69531
100
1.699951
0.299988
0.699951
131
7.449219
null
null
null
null
0
<2 mo. follow-up
0
8,363
75.52594
1
male
1
9
9
Coma
Coma
1
10
>$50k
44
79,205
53,814.1875
50,481.6562
36.5
white
21.398438
41
0.338989
0.265991
18
0
0
no
0.5
0.5
dnr after sadm
8
75
32.796875
68
12
39.19531
204
2.299805
1.199951
1.899902
141
7.509766
null
null
null
null
0
<2 mo. follow-up
0
8,364
61.51398
1
male
0
7
107
Lung Cancer
Cancer
2
12
null
0
8,858
5,507.6953
5,136.6875
13
white
13.398438
19
0.779907
0.540894
1
0
0
metastatic
0.5
0.25
dnr after sadm
1
75
null
77
22
37.79688
null
null
null
1.399902
139
null
null
null
null
null
1
no(M2 and SIP pres)
1
8,365
51.87698
1
male
0
15
1,228
CHF
COPD/CHF/Cirrhosis
2
12
$11-$25k
0
12,740
8,003.8203
10,091.0625
13.666664
white
19.597656
33
0.897949
0.828979
1
0
0
no
0.9
0.5
no dnr
15
79
10.599609
98
24
35.59375
361.875
4
1.399902
1.699951
135
7.459961
null
null
null
null
0
null
0
8,366
40.93597
0
female
0
10
1,371
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$11-$25k
0
9,355
6,916.2422
5,496.94922
9
white
34.5
53
0.72998
0.646973
1
1
0
no
1
0.9
no dnr
10
109
12.898438
108
22
37.69531
93.875
null
0.199982
7.299805
129
7.349609
null
null
null
0
0
no(M2 and SIP pres)
0
8,367
52.93597
1
male
1
11
11
ARF/MOSF w/Sepsis
ARF/MOSF
1
13
>$50k
0
37,033
24,434.8125
21,937.4375
45.5
white
53.59375
88
0.153992
0.074997
1
1
0
no
null
null
dnr after sadm
8
39
16.898438
154
28
39.29688
102.84375
2.5
4.199219
3.399902
144
7.379883
null
null
null
null
1
<2 mo. follow-up
1
8,368
77.23999
1
male
0
17
168
ARF/MOSF w/Sepsis
ARF/MOSF
6
6
$11-$25k
0
19,734
14,627.5234
11,903.375
15.333328
white
27.898438
50
0.668945
0.572998
2
1
0
no
0.05
0.000125
no dnr
17
63
13.5
124
28
37.59375
null
4
0.5
2.799805
147
null
null
null
null
null
null
no(M2 and SIP pres)
4.344727
8,369
74.04498
1
male
0
26
33
MOSF w/Malig
ARF/MOSF
1
14
$25-$50k
0
75,250
48,129.75
52,292.5312
21.75
white
22.597656
24
0.618896
0.513916
23
0
0
yes
0.2
0.008
dnr after sadm
25
105
5.199219
104
36
36.59375
352.5
null
null
1.399902
141
7.769531
null
null
null
null
5
<2 mo. follow-up
5
8,370
78.33496
1
male
0
14
267
COPD
COPD/CHF/Cirrhosis
3
5
$11-$25k
0
20,412
13,551.75
13,804.8281
21
white
23.296875
47
0.73999
0.591919
1
0
0
no
0
0
dnr after sadm
1
120
13.898438
59
33
37.79688
180
3.799805
0.899902
2.199707
134
7.299805
null
null
null
null
1
adl>=4 (>=5 if sur)
1
8,371
48.63797
1
male
1
3
3
ARF/MOSF w/Sepsis
ARF/MOSF
5
12
$25-$50k
100
11,142
7,791.1289
7,995.87891
63
white
50.796875
70
0.003
0
1
1
0
no
null
null
dnr after sadm
3
42
15.699219
68
35
34.19531
110.20312
2
1.899902
2.599609
154
7.539062
null
null
null
null
null
<2 mo. follow-up
4.214844
8,372
74.52197
1
male
0
7
794
COPD
COPD/CHF/Cirrhosis
1
8
under $11k
9
4,039
2,678.4492
3,494.80859
7
white
14.898438
18
0.858887
0.767944
1
0
0
no
0.9
0.9
dnr after sadm
1
79
8.298828
73
24
35.89844
186.65625
4.099609
0.399963
0.699951
140
7.389648
null
null
null
null
0
no(M2 and SIP pres)
0
8,373
29.97899
0
male
0
73
1,362
ARF/MOSF w/Sepsis
ARF/MOSF
1
14
under $11k
9
123,456
92,438
91,346.0625
16.5
white
20.796875
23
0.841919
0.787964
20
0
0
yes
0.75
0.7
no dnr
73
77
14.5
126
30
37.79688
240
2.599609
0.399963
0.899902
141
7.389648
null
null
null
null
0
adl>=4 (>=5 if sur)
0
8,374
52.02197
0
female
0
10
1,361
Colon Cancer
Cancer
1
null
null
0
15,758
10,225.4141
10,733.2656
22.5
white
17.796875
21
0.828979
0.628906
1
0
0
metastatic
1
0.1
no dnr
10
113
10
70
10
35.79688
282
null
null
0.799927
135
7.479492
null
null
null
null
null
null
2.312988
8,375
71.00598
1
female
0
6
28
CHF
COPD/CHF/Cirrhosis
2
17
under $11k
0
3,023
2,051.9375
1,920.01953
6
white
45
52
0.272949
0.103989
1
0
0
no
0.9
0.6
no dnr
6
29
5.799805
59
24
37
null
3.099609
0.599976
5
132
null
null
null
null
1
0
<2 mo. follow-up
0
8,376
63.918
1
male
0
40
65
Coma
Coma
4
null
null
61
60,050
77,295.875
85,570.625
36.5
white
23.199219
27
0.440979
0.366943
1
1
0
no
0.95
0.8
dnr after sadm
3
61
17.597656
78
6
37.89844
94.28125
2.799805
1.699951
1.199951
139
7.579102
null
null
null
null
null
null
2.715332
8,377
79.31799
1
male
0
4
14
Cirrhosis
COPD/CHF/Cirrhosis
5
6
null
44
10,346
6,697.7539
10,274.2031
21
white
28.296875
75
0.212982
0.066986
1
0
1
no
null
null
dnr after sadm
1
57
5.299805
112
36
39.59375
485.6875
1.699951
2.699707
2.099609
148
7.469727
null
null
null
null
6
<2 mo. follow-up
6
8,378
75.58698
1
female
0
5
809
CHF
COPD/CHF/Cirrhosis
4
14
$11-$25k
0
2,641
1,807.6631
1,603.5293
11
white
17.699219
32
0.855957
0.762939
1
1
0
no
null
null
no dnr
5
75
8.898438
70
20
35.69531
null
3.699707
1.899902
1.5
136
null
null
null
null
0
2
no(M2 and SIP pres)
2
8,379
65.875
0
male
0
5
1,350
Lung Cancer
Cancer
2
11
under $11k
0
5,483
3,792.6484
3,592.72852
10
white
24.699219
28
0.522949
0.200989
1
0
0
metastatic
0.75
0.5
no dnr
5
71
22.898438
67
26
35.09375
null
3.799805
0.5
0.899902
124
null
null
null
null
null
null
no(M2 and SIP pres)
2.420898
8,380
60.53897
1
female
1
3
3
Coma
Coma
1
null
null
0
42,868
27,519.3594
26,107.1094
59
null
46
66
0.084991
0.048996
6
0
0
no
null
null
no dnr
3
43
17.699219
140
12
38.69531
132.71875
null
null
5.299805
130
7.319336
null
null
null
null
1
<2 mo. follow-up
1
8,381
72.34998
0
male
0
42
1,349
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
100
112,532
79,493.25
77,019.1875
29.75
white
21.097656
41
0.327942
0.212982
13
0
0
no
0.7
0.5
no dnr
42
69
10.199219
78
40
39.89844
240
null
null
1.699951
146
7.469727
null
null
null
null
0
null
0
8,382
78.80396
1
male
0
9
258
Cirrhosis
COPD/CHF/Cirrhosis
2
14
$11-$25k
0
4,893
3,245.4336
3,003.36914
10.5
white
21
24
0.638916
0.458984
1
0
0
no
0.95
0.8
dnr after sadm
1
97
4.5
74
16
35.19531
null
3.599609
0.699951
1.799805
133
null
null
null
null
2
2
no(M2 and SIP pres)
2
8,383
87.70398
1
male
0
14
380
COPD
COPD/CHF/Cirrhosis
4
null
null
0
9,576
6,121.2734
5,868
13
white
16.398438
42
0.738892
0.589966
1
0
0
yes
0.6
0.5
dnr after sadm
1
103
6.399414
96
28
38
204.75
3.799805
1.099854
1.5
139
7.379883
null
null
null
null
null
null
4.556641
8,384
54.52197
1
male
0
20
137
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$25-$50k
0
81,712
49,968.125
51,202.75
21.333328
white
24.296875
24
0.717896
0.631958
38
0
0
yes
0.5
0.2
no dnr
20
75
4.899414
126
28
36.29688
346.9375
null
null
1.099854
140
7.439453
null
null
null
null
5
null
5
8,385
75.30194
1
male
0
8
632
Colon Cancer
Cancer
2
8
$11-$25k
0
11,949
7,253.4805
7,676.88672
17
white
16.296875
24
0.807983
0.589966
1
0
0
metastatic
0.9
0.7
no dnr
8
73
5.399414
96
24
38.09375
null
null
null
1.299805
132
null
null
null
null
null
0
no(M2 and SIP pres)
0
8,386
65.17499
0
male
0
28
1,347
COPD
COPD/CHF/Cirrhosis
2
12
under $11k
26
31,065
19,741.4375
19,872.3594
17
white
26
39
0.707886
0.547974
1
0
0
no
0.9
0.8
dnr after sadm
1
79
7.899414
103
36
37.89844
185.6875
2.399902
0.599976
1
138
7.469727
null
null
null
null
3
adl>=4 (>=5 if sur)
3
8,387
22.88799
1
male
0
40
604
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
under $11k
0
54,848
37,453.5625
39,282.1562
27
white
35.195313
62
0.730957
0.647949
10
0
0
no
0.8
0.8
no dnr
40
63
21.796875
140
50
36.09375
182.84375
2
3.5
0.399963
137
7.449219
null
null
null
null
7
adl>=4 (>=5 if sur)
7
8,388
61.30899
1
male
0
31
730
ARF/MOSF w/Sepsis
ARF/MOSF
1
9
$11-$25k
0
135,370
82,462.5
88,001.9375
21.5
white
29.199219
36
0.572998
0.462952
28
0
0
yes
null
null
no dnr
31
116
0.099991
112
24
36.19531
353
null
null
1.199951
135
7.5
null
null
null
null
0
no(M2 and SIP pres)
0
8,389
62.073
1
male
0
11
68
Lung Cancer
Cancer
1
12
under $11k
0
6,530
4,838.1602
5,611.51953
2
white
4.399414
20
0.886963
0.74292
1
0
0
metastatic
null
null
no dnr
11
115
14.699219
73
24
36.29688
357.125
4.599609
0.399963
1.199951
134
7.459961
null
null
null
null
null
no(M2 and SIP pres)
2.161133
8,390
63.22198
1
male
0
5
632
Lung Cancer
Cancer
1
null
null
0
6,315
null
null
7
white
14.5
17
0.757935
0.50293
1
0
0
metastatic
0.9
0.8
no dnr
5
75
6.699219
83
18
36.39844
null
null
null
1.099854
136
null
null
null
null
null
null
null
1.941162
8,391
81.21594
1
male
1
6
6
MOSF w/Malig
ARF/MOSF
1
null
null
0
18,554
13,085.6641
13,771.9297
32
white
25.898438
42
0.578979
0.468994
4
0
0
yes
null
null
dnr after sadm
4
59
77.390625
58
30
36.79688
155.09375
null
null
1.5
138
7.339844
null
null
null
null
0
<2 mo. follow-up
0
8,392
68.43799
0
male
0
9
1,335
Colon Cancer
Cancer
2
12
$11-$25k
0
12,932
7,977.168
7,868.26953
19
white
18.199219
23
0.793945
0.563965
1
1
0
metastatic
0.98
0.8
no dnr
9
113
12.599609
76
16
36.19531
null
null
null
1.599854
137
null
null
null
null
1
0
no(M2 and SIP pres)
0
8,393
59.53198
1
female
1
6
6
MOSF w/Malig
ARF/MOSF
1
14
$25-$50k
0
9,529
6,561.9961
6,822.88672
29
white
37.296875
77
0.242981
0.140991
2
0
0
metastatic
0.1
0.001
dnr after sadm
5
61
9.699219
120
28
36.39844
207.5
1.699951
15.5
4.099609
135
7.439453
null
null
null
null
0
<2 mo. follow-up
0
8,394
76.70599
1
male
0
17
18
COPD
COPD/CHF/Cirrhosis
3
11
under $11k
44
46,129
29,804.6719
32,551.4844
38.333313
white
31
44
0.337952
0.15097
2
0
0
no
null
null
dnr after sadm
15
70
15.898438
116
40
38.29688
215
1.799805
0.299988
1
140
7.389648
null
null
null
null
6
<2 mo. follow-up
6
8,395
73.26996
0
female
0
46
1,335
COPD
COPD/CHF/Cirrhosis
2
null
null
26
65,771
44,039.9375
44,007.4688
27
white
27.699219
41
0.590942
0.398987
1
0
0
no
0.5
0.5
dnr after sadm
30
55
7.299805
71
8
37.59375
187.5
2.799805
0.899902
2.5
142
7.669922
null
null
null
null
null
null
3.068359
8,396
53.66199
1
male
0
5
90
Lung Cancer
Cancer
1
11
null
26
5,210
3,389.5176
3,521.0293
12
white
24.597656
8
0.435974
0.127991
1
0
0
metastatic
0.2
0.1
dnr after sadm
1
104
3.399902
69
24
37
344.4375
2.599609
0.399963
0.699951
142
7.40918
null
null
null
null
null
no(M2 and SIP pres)
2.515137
8,397
81.62598
1
male
0
7
180
COPD
COPD/CHF/Cirrhosis
5
7
null
9
4,685
3,020.8144
3,273.85938
18
white
15.599609
36
0.768921
0.632935
1
0
1
yes
0.5
0.5
no dnr
7
74
4.899414
81
24
36.09375
233.3125
null
null
0.899902
145
7.379883
null
null
null
null
2
no(M2 and SIP pres)
2
8,398
43.63898
1
male
0
35
39
Coma
Coma
0
12
$25-$50k
100
22,306
27,158.3594
28,949.3125
22.75
white
23.5
23
0.438965
0.365967
1
0
0
no
null
null
dnr after sadm
11
114
25.796875
74
34
36.09375
445
2.699707
0.899902
0.699951
129
7.5
null
null
null
null
1
<2 mo. follow-up
1
8,399
69.47797
0
female
0
15
1,329
CHF
COPD/CHF/Cirrhosis
2
14
$25-$50k
0
11,658
7,918.2812
7,724.65625
12
white
17
20
0.878906
0.79895
1
0
0
no
0.8
0.8
no dnr
15
65
null
63
20
36
null
null
null
1.199951
135
null
null
null
null
0
0
no(M2 and SIP pres)
0
8,400
76.96594
1
male
0
51
85
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
under $11k
26
158,804
111,121.562
106,241.5
30
white
18.898438
32
0.620972
0.515991
30
0
0
yes
null
null
dnr after sadm
16
79
11.699219
80
40
38.69531
223.3125
null
null
1.399902
146
7.439453
null
null
null
null
6
adl>=4 (>=5 if sur)
6